{"count": 57, "results": [{"_id": "36482884", "pmid": 36482884, "pmcid": "PMC9725923", "title": "Metformin Inducing the Change of Functional and Exhausted Phenotypic Tumor-Infiltrated Lymphocytes and the Correlation with JNK Signal Pathway in Triple-Negative Breast Cancer", "journal": "Breast Cancer (Dove Med Press)", "authors": ["Wang R", "Li Y", "Zhao Y", "Shi F", "Zhou Q", "Wu J", "Lyu S", "Song Q"], "date": "2022-12-02T00:00:00Z", "doi": "10.2147/BCTT.S384702", "meta_date_publication": "2022", "meta_volume": "14", "meta_issue": "", "meta_pages": "391-403", "score": 50285.37, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ had the potential to combined immunotherapy for @<m>DISEASE_Triple_Negative_Breast_Neoplasms</m> @DISEASE_MESH:D064726 @@@TNBC@@@.", "citations": {"NLM": "Wang R, Li Y, Zhao Y, Shi F, Zhou Q, Wu J, Lyu S, Song Q. Metformin Inducing the Change of Functional and Exhausted Phenotypic Tumor-Infiltrated Lymphocytes and the Correlation with JNK Signal Pathway in Triple-Negative Breast Cancer Breast Cancer (Dove Med Press). 2022;14():391-403. PMID: 36482884", "BibTeX": "@article{36482884, title={Metformin Inducing the Change of Functional and Exhausted Phenotypic Tumor-Infiltrated Lymphocytes and the Correlation with JNK Signal Pathway in Triple-Negative Breast Cancer}, author={Wang R and Li Y and Zhao Y and Shi F and Zhou Q and Wu J and Lyu S and Song Q}, journal={Breast Cancer (Dove Med Press)}, volume={14}, pages={391-403}}"}}, {"_id": "40430851", "pmid": 40430851, "title": "Metformin-Based Combination Approaches for Triple-Negative Breast Cancer.", "journal": "Pharmaceutics", "authors": ["Sirhan Z", "Abu Nada A", "Anabtawi N", "Thyagarajan A", "Sahu RP"], "date": "2025-04-24T00:00:00Z", "doi": "10.3390/pharmaceutics17050558", "meta_date_publication": "2025 Apr 24", "meta_volume": "17", "meta_issue": "5", "meta_pages": "", "score": 50271.965, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@-Based Combination Approaches for @<m>DISEASE_Triple_Negative_Breast_Neoplasms</m> @DISEASE_MESH:D064726 @@@Triple-Negative Breast Cancer@@@.", "citations": {"NLM": "Sirhan Z, Abu Nada A, Anabtawi N, Thyagarajan A, Sahu RP. Metformin-Based Combination Approaches for Triple-Negative Breast Cancer. Pharmaceutics. 2025 Apr 24;17(5):. PMID: 40430851", "BibTeX": "@article{40430851, title={Metformin-Based Combination Approaches for Triple-Negative Breast Cancer.}, author={Sirhan Z and Abu Nada A and Anabtawi N and Thyagarajan A and Sahu RP}, journal={Pharmaceutics}, volume={17}, number={5}}"}}, {"_id": "37632970", "pmid": 37632970, "title": "The Effect of Metformin on Triple-Negative Breast Cancer Cells and Nude Mice.", "journal": "Altern Ther Health Med", "authors": ["Song J", "Du J", "Han L", "Lin X", "Fan C", "Chen G"], "date": "2023-08-25T00:00:00Z", "meta_date_publication": "2023 Aug 25", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50269.938, "text_hl": "The Effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ on @<m>DISEASE_Triple_Negative_Breast_Neoplasms</m> @DISEASE_MESH:D064726 @@@Triple-Negative Breast Cancer@@@ Cells and Nude Mice.", "citations": {"NLM": "Song J, Du J, Han L, Lin X, Fan C, Chen G. The Effect of Metformin on Triple-Negative Breast Cancer Cells and Nude Mice. Altern Ther Health Med. 2023 Aug 25;():. PMID: 37632970", "BibTeX": "@article{37632970, title={The Effect of Metformin on Triple-Negative Breast Cancer Cells and Nude Mice.}, author={Song J and Du J and Han L and Lin X and Fan C and Chen G}, journal={Altern Ther Health Med}}"}}, {"_id": "35267651", "pmid": 35267651, "pmcid": "PMC8909901", "title": "Dual Effect of Combined Metformin and 2-Deoxy-D-Glucose Treatment on Mitochondrial Biogenesis and PD-L1 Expression in Triple-Negative Breast Cancer Cells", "journal": "Cancers (Basel)", "authors": ["Repas J", "Zupin M", "Vodlan M", "Veranič P", "Gole B", "Potočnik U", "Pavlin M"], "date": "2022-03-05T00:00:00Z", "doi": "10.3390/cancers14051343", "meta_date_publication": "2022 Mar 5", "meta_volume": "14", "meta_issue": "5", "meta_pages": "", "score": 50268.715, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ + @CHEMICAL_Deoxyglucose @CHEMICAL_MESH:D003847 @@@2DG@@@ increased mitochondrial mass in @<m>DISEASE_Triple_Negative_Breast_Neoplasms</m> @DISEASE_MESH:D064726 @@@TNBC@@@ cells. ", "citations": {"NLM": "Repas J, Zupin M, Vodlan M, Veranič P, Gole B, Potočnik U, Pavlin M. Dual Effect of Combined Metformin and 2-Deoxy-D-Glucose Treatment on Mitochondrial Biogenesis and PD-L1 Expression in Triple-Negative Breast Cancer Cells Cancers (Basel). 2022 Mar 5;14(5):. PMID: 35267651", "BibTeX": "@article{35267651, title={Dual Effect of Combined Metformin and 2-Deoxy-D-Glucose Treatment on Mitochondrial Biogenesis and PD-L1 Expression in Triple-Negative Breast Cancer Cells}, author={Repas J and Zupin M and Vodlan M and Veranič P and Gole B and Potočnik U and Pavlin M}, journal={Cancers (Basel)}, volume={14}, number={5}}"}}, {"_id": "33854147", "pmid": 33854147, "pmcid": "PMC8047046", "title": "Repositioning metformin and propranolol for colorectal and triple negative breast cancers treatment", "journal": "Sci Rep", "authors": ["Anselmino LE", "Baglioni MV", "Malizia F", "Laluce NC", "Etichetti CB", "Marignac VLM", "Rozados V", "Scharovsky OG", "Girardini J", "Rico MJ", "Menacho Márquez M"], "date": "2021-04-14T00:00:00Z", "doi": "10.1038/s41598-021-87525-z", "meta_date_publication": "2021 Apr 14", "meta_volume": "11", "meta_issue": "1", "meta_pages": "8091", "score": 50265.574, "text_hl": "Repositioning @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and @CHEMICAL_Propranolol @CHEMICAL_MESH:D011433 @@@propranolol@@@ for @<m>DISEASE_Triple_Negative_Breast_Neoplasms</m> @DISEASE_MESH:D064726 @@@colorectal and triple negative breast cancers@@@ treatment", "citations": {"NLM": "Anselmino LE, Baglioni MV, Malizia F, Laluce NC, Etichetti CB, Marignac VLM, Rozados V, Scharovsky OG, Girardini J, Rico MJ, Menacho Márquez M. Repositioning metformin and propranolol for colorectal and triple negative breast cancers treatment Sci Rep. 2021 Apr 14;11(1):8091. PMID: 33854147", "BibTeX": "@article{33854147, title={Repositioning metformin and propranolol for colorectal and triple negative breast cancers treatment}, author={Anselmino LE and Baglioni MV and Malizia F and Laluce NC and Etichetti CB and Marignac VLM and Rozados V and Scharovsky OG and Girardini J and Rico MJ and Menacho Márquez M}, journal={Sci Rep}, volume={11}, number={1}, pages={8091}}"}}, {"_id": "31570268", "pmid": 31570268, "title": "Phase 1 Study of Erlotinib and Metformin in Metastatic Triple-Negative Breast Cancer.", "journal": "Clin Breast Cancer", "authors": ["Fenn K", "Maurer M", "Lee SM", "Crew KD", "Trivedi MS", "Accordino MK", "Hershman DL", "Kalinsky K"], "date": "2020-02-01T00:00:00Z", "doi": "10.1016/j.clbc.2019.08.004", "meta_date_publication": "2020 Feb", "meta_volume": "20", "meta_issue": "1", "meta_pages": "80-86", "score": 50263.516, "text_hl": "Phase 1 Study of @CHEMICAL_Erlotinib_Hydrochloride @CHEMICAL_MESH:D000069347 @@@Erlotinib@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ in Metastatic @<m>DISEASE_Triple_Negative_Breast_Neoplasms</m> @DISEASE_MESH:D064726 @@@Triple-Negative Breast Cancer@@@.", "citations": {"NLM": "Fenn K, Maurer M, Lee SM, Crew KD, Trivedi MS, Accordino MK, Hershman DL, Kalinsky K. Phase 1 Study of Erlotinib and Metformin in Metastatic Triple-Negative Breast Cancer. Clin Breast Cancer. 2020 Feb;20(1):80-86. PMID: 31570268", "BibTeX": "@article{31570268, title={Phase 1 Study of Erlotinib and Metformin in Metastatic Triple-Negative Breast Cancer.}, author={Fenn K and Maurer M and Lee SM and Crew KD and Trivedi MS and Accordino MK and Hershman DL and Kalinsky K}, journal={Clin Breast Cancer}, volume={20}, number={1}, pages={80-86}}"}}, {"_id": "37008735", "pmid": 37008735, "pmcid": "PMC10064789", "title": "Relaxin-encapsulated polymeric metformin nanoparticles remodel tumor immune microenvironment by reducing CAFs for efficient triple-negative breast cancer immunotherapy", "journal": "Asian J Pharm Sci", "authors": ["Zhang H", "Chen L", "Zhao Y", "Luo N", "Shi J", "Xu S", "Ma L", "Wang M", "Gu M", "Mu C", "Xiong Y"], "date": "2023-03-01T00:00:00Z", "doi": "10.1016/j.ajps.2023.100796", "meta_date_publication": "2023 Mar", "meta_volume": "18", "meta_issue": "2", "meta_pages": "100796", "score": 50263.18, "text_hl": "In view of this concern, we introduced the polymeric @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (PolyMet) to form PolyMet-pRLN complex. ", "citations": {"NLM": "Zhang H, Chen L, Zhao Y, Luo N, Shi J, Xu S, Ma L, Wang M, Gu M, Mu C, Xiong Y. Relaxin-encapsulated polymeric metformin nanoparticles remodel tumor immune microenvironment by reducing CAFs for efficient triple-negative breast cancer immunotherapy Asian J Pharm Sci. 2023 Mar;18(2):100796. PMID: 37008735", "BibTeX": "@article{37008735, title={Relaxin-encapsulated polymeric metformin nanoparticles remodel tumor immune microenvironment by reducing CAFs for efficient triple-negative breast cancer immunotherapy}, author={Zhang H and Chen L and Zhao Y and Luo N and Shi J and Xu S and Ma L and Wang M and Gu M and Mu C and Xiong Y}, journal={Asian J Pharm Sci}, volume={18}, number={2}, pages={100796}}"}}, {"_id": "32546966", "pmid": 32546966, "pmcid": "PMC7260544", "title": "A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer", "journal": "Drug Des Devel Ther", "authors": ["Sambi M", "Samuel V", "Qorri B", "Haq S", "Burov SV", "Markvicheva E", "Harless W", "Szewczuk MR"], "date": "2020-05-25T00:00:00Z", "doi": "10.2147/DDDT.S242514", "meta_date_publication": "2020", "meta_volume": "14", "meta_issue": "", "meta_pages": "1995-2019", "score": 50261.98, "text_hl": "@CHEMICAL_Aspirin @CHEMICAL_MESH:D001241 @@@Acetylsalicylic acid@@@ (@CHEMICAL_Aspirin @CHEMICAL_MESH:D001241 @@@ASA@@@), @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (@GENE_SLTM @GENE_79811 @@@Met@@@), and @CHEMICAL_Oseltamivir @CHEMICAL_MESH:D053139 @@@oseltamivir phosphate@@@ (@CHEMICAL_ornithine_phenylacetate @CHEMICAL_MESH:C572232 @@@OP@@@) were investigated for their efficacy to sensitize @CELLLINE_CVCL:0062 @@@MDA-MB-231@@@ @<m>DISEASE_Triple_Negative_Breast_Neoplasms</m> @DISEASE_MESH:D064726 @@@triple-negative breast cancer@@@ and its @CHEMICAL_Tamoxifen @CHEMICAL_MESH:D013629 @@@tamoxifen@@@ (@CHEMICAL_Tamoxifen @CHEMICAL_MESH:D013629 @@@Tmx@@@) resistant variant (@CELLLINE_CVCL:0062 @@@MDA-MB-231@@@-TmxR) together in combination with @CHEMICAL_Tamoxifen @CHEMICAL_MESH:D013629 @@@Tmx@@@ treatment.", "citations": {"NLM": "Sambi M, Samuel V, Qorri B, Haq S, Burov SV, Markvicheva E, Harless W, Szewczuk MR. A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer Drug Des Devel Ther. 2020;14():1995-2019. PMID: 32546966", "BibTeX": "@article{32546966, title={A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer}, author={Sambi M and Samuel V and Qorri B and Haq S and Burov SV and Markvicheva E and Harless W and Szewczuk MR}, journal={Drug Des Devel Ther}, volume={14}, pages={1995-2019}}"}}, {"_id": "32940848", "pmid": 32940848, "title": "Metformin and an insulin/IGF-1 receptor inhibitor are synergistic in blocking growth of triple-negative breast cancer.", "journal": "Breast Cancer Res Treat", "authors": ["Xue L", "Chen F", "Yue F", "Camacho L", "Kothapalli S", "Wei G", "Huang S", "Mo Q", "Ma F", "Li Y", "Jiralerspong S"], "date": "2021-01-01T00:00:00Z", "doi": "10.1007/s10549-020-05927-5", "meta_date_publication": "2021 Jan", "meta_volume": "185", "meta_issue": "1", "meta_pages": "73-84", "score": 50261.977, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and an insulin/IGF-1 receptor inhibitor are synergistic in blocking growth of @<m>DISEASE_Triple_Negative_Breast_Neoplasms</m> @DISEASE_MESH:D064726 @@@triple-negative breast cancer@@@.", "citations": {"NLM": "Xue L, Chen F, Yue F, Camacho L, Kothapalli S, Wei G, Huang S, Mo Q, Ma F, Li Y, Jiralerspong S. Metformin and an insulin/IGF-1 receptor inhibitor are synergistic in blocking growth of triple-negative breast cancer. Breast Cancer Res Treat. 2021 Jan;185(1):73-84. PMID: 32940848", "BibTeX": "@article{32940848, title={Metformin and an insulin/IGF-1 receptor inhibitor are synergistic in blocking growth of triple-negative breast cancer.}, author={Xue L and Chen F and Yue F and Camacho L and Kothapalli S and Wei G and Huang S and Mo Q and Ma F and Li Y and Jiralerspong S}, journal={Breast Cancer Res Treat}, volume={185}, number={1}, pages={73-84}}"}}, {"_id": "38459750", "pmid": 38459750, "title": "Design, optimization, characterization, and in vitro evaluation of metformin-loaded liposomes for triple negative breast cancer treatment.", "journal": "J Liposome Res", "authors": ["Vozgirdaite D", "Hervé-Aubert K", "Uzbekov R", "Chourpa I", "Allard-Vannier E"], "date": "2024-03-08T00:00:00Z", "doi": "10.1080/08982104.2024.2321528", "meta_date_publication": "2024 Mar 8", "meta_volume": "", "meta_issue": "", "meta_pages": "1-15", "score": 50261.78, "text_hl": "Design, optimization, characterization, and in vitro evaluation of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-loaded liposomes for @<m>DISEASE_Triple_Negative_Breast_Neoplasms</m> @DISEASE_MESH:D064726 @@@triple negative breast cancer@@@ treatment.", "citations": {"NLM": "Vozgirdaite D, Hervé-Aubert K, Uzbekov R, Chourpa I, Allard-Vannier E. Design, optimization, characterization, and in vitro evaluation of metformin-loaded liposomes for triple negative breast cancer treatment. J Liposome Res. 2024 Mar 8;():1-15. PMID: 38459750", "BibTeX": "@article{38459750, title={Design, optimization, characterization, and in vitro evaluation of metformin-loaded liposomes for triple negative breast cancer treatment.}, author={Vozgirdaite D and Hervé-Aubert K and Uzbekov R and Chourpa I and Allard-Vannier E}, journal={J Liposome Res}, pages={1-15}}"}}]}